WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / July 2026 / K261210

510(k) cleared

Cleerly Plaque

Cleerly, Inc. · Jul 29, 2026 · K261210

FDA cleared the Cleerly Plaque from Cleerly, Inc. on Jul 29, 2026 under K261210, a traditional 510(k). The device falls under product code QIH, Automated Radiological Image Processing Software, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Apr 14, 2026. The decision came 106 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Cleerly, Inc. has one other decision in the tracker over the last 12 months: K260588 (Cleerly LABS).

Questions & Answers

What did FDA clear under K261210?

K261210 is the FDA 510(k) for Cleerly Plaque, submitted by Cleerly, Inc.. FDA's decision date was Jul 29, 2026, under product code QIH (Automated Radiological Image Processing Software).

Who makes the Cleerly Plaque?

Cleerly, Inc., based in Denver, CO, is the applicant of record for K261210.

How long did the K261210 review take?

FDA received the submission on Apr 14, 2026 and issued its decision on Jul 29, 2026, 106 days later.

← All decisions in July 2026

Sources